rs786203999
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_133443.4(GPT2):c.459C>G(p.Ser153Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_133443.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPT2 | NM_133443.4 | c.459C>G | p.Ser153Arg | missense_variant | Exon 5 of 12 | ENST00000340124.9 | NP_597700.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPT2 | ENST00000340124.9 | c.459C>G | p.Ser153Arg | missense_variant | Exon 5 of 12 | 1 | NM_133443.4 | ENSP00000345282.4 | ||
GPT2 | ENST00000440783.2 | c.159C>G | p.Ser53Arg | missense_variant | Exon 5 of 12 | 2 | ENSP00000413804.2 | |||
GPT2 | ENST00000562132.5 | c.225C>G | p.Ser75Arg | missense_variant | Exon 4 of 5 | 4 | ENSP00000457475.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.459C>G (p.S153R) alteration is located in exon 5 (coding exon 4) of the GPT2 gene. This alteration results from a C to G substitution at nucleotide position 459, causing the serine (S) at amino acid position 153 to be replaced by an arginine (R). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been observed in the homozygous state in three siblings with developmental delay, microcephaly, and spastic paraplegia (Iglesias, 2014; Celis, 2015). This amino acid position is highly conserved in available vertebrate species. In vitro functional assays show reduced enzyme activity for this variant compared to control (Celis, 2015; Ouyang, 2016). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
Glutamate pyruvate transaminase 2 deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at